INGROSSO, Diego
 Distribuzione geografica
Continente #
EU - Europa 2.879
NA - Nord America 2.405
AS - Asia 199
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 5.490
Nazione #
US - Stati Uniti d'America 2.401
IE - Irlanda 890
UA - Ucraina 407
IT - Italia 371
GB - Regno Unito 349
DE - Germania 305
FR - Francia 206
SE - Svezia 148
FI - Finlandia 108
CN - Cina 103
TR - Turchia 71
GR - Grecia 59
BE - Belgio 19
VN - Vietnam 12
PL - Polonia 7
CA - Canada 4
NL - Olanda 4
EU - Europa 3
IN - India 3
SA - Arabia Saudita 3
AT - Austria 2
IR - Iran 2
MK - Macedonia 2
SC - Seychelles 2
AU - Australia 1
CH - Svizzera 1
ID - Indonesia 1
IQ - Iraq 1
JP - Giappone 1
KR - Corea 1
PK - Pakistan 1
RO - Romania 1
TN - Tunisia 1
Totale 5.490
Città #
Dublin 884
Jacksonville 629
Chandler 471
Princeton 117
Bremen 114
Medford 106
Ann Arbor 80
Caserta 80
San Mateo 73
Boardman 70
Roxbury 57
Woodbridge 57
Beijing 47
Wilmington 44
Camerino 38
Naples 27
Düsseldorf 26
Cambridge 24
Des Moines 24
New York 24
Brussels 18
Mountain View 16
Ashburn 13
London 13
Nanjing 13
Dong Ket 12
Napoli 12
Houston 11
Rome 10
Norwalk 9
Milan 8
Venice 8
Los Angeles 7
Dundalk 6
Shenyang 6
Auburn Hills 5
Jinan 5
Avellino 4
Helsinki 4
Lioni 4
Radomsko 4
Tianjin 4
Bergamo 3
Casavatore 3
Casoria 3
Castellammare Di Stabia 3
Fairfield 3
Grafing 3
Guangzhou 3
Haikou 3
Lappeenranta 3
Makkah 3
Mondragone 3
Nanchang 3
Ningbo 3
Salerno 3
Zhengzhou 3
Çorum 3
Adelfia 2
Altamura 2
Bagno A Ripoli 2
Bologna 2
Brembate di Sopra 2
Cagliari 2
Carife 2
Coperchia 2
Elora 2
Frattaminore 2
Hangzhou 2
Hefei 2
Kraków 2
Potenza 2
Redwood City 2
Rockville 2
San Paolo Bel Sito 2
Santa Clara 2
Saviano 2
Taiyuan 2
Torino 2
Vienna 2
Abbadia Lariana 1
Amsterdam 1
Ancona 1
Aosta 1
Apo 1
Artena 1
Aversa 1
Baghdad 1
Battipaglia 1
Boydton 1
Casapulla 1
Changchun 1
Chengdu 1
Chennai 1
Colle di Val d'Elsa 1
Darmstadt 1
Dearborn 1
Fontanarosa 1
Groningen 1
Gunzenhausen 1
Totale 3.296
Nome #
C-reactive protein is released in the coronary circulation and causes endothelial dysfunction in patients with acute coronary syndromes. 100
The 1,4 benzoquinone-featured 5-lipoxygenase inhibitor RF-Id induces apoptotic death through downregulation of IAPs in human glioblastoma cells 83
A miRNA signature suggestive of nodal metastases from laryngeal carcinoma. 79
Renal phenotype in bardet-biedl syndrome: A combined defect of urinary concentration and dilution is associated with defective urinary aqp2 and umod excretion 74
INIBIZIONE DELLA METIL-ESTERIFICAZIONE ENZIMATICA DELLE PROTEINE DI MEMBRANA E SUO SIGNIFICATO NELL'UREMIA:RUOLO DELL'OMOCISTEINA 73
Cytoskeletal behaviour in spectrin and in band 3 deficient spherocytic red cells: Evidence for a differentiated splenic conditioning role 72
The Sulfur Metabolite Lanthionine: Evidence for a Role as a Novel Uremic Toxin 71
Enzymatic methyl esterification of synthetic tripeptides: structural requirements of the peptide substrate.Detection of the reaction products by fast-atom-bombardment mass spectrometry 70
Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins 70
Marks' Basic Medical Biochemistry: A Clinical Approach 70
Impact of the uremic milieu on the osteogenic potential of mesenchymal stem cells 69
Atherosclerosis determinants in renal disease: How much is homocysteine involved? 68
Hyperhomocysteinemia in Chronic Renal Failure: Alternative Therapeutic Strategies 66
ADAM17, a New Player in the Pathogenesis of Chronic Kidney Disease–Mineral and Bone Disorder 65
Gases as Uremic Toxins: Is There Something in the Air? 64
The gasotransmitter hydrogen sulfide in hemodialysis patients 64
Two different serum MiRNA signatures correlate with the clinical outcome and histological subtype in pleural malignant mesothelioma patients 64
Hydrogen sulfide reduces cell adhesion and relevant inflammatory triggering by preventing ADAM17-dependent TNF-α activation 63
Adverse effects of hyperhomocysteinemia and their management by folic acid 63
Altered folate receptor 2 expression in uraemic patients on haemodialysis: Implications for folate resistance 62
Transferrin-targeted nanoparticles containing zoledronic acid as a potential to inhibit glioblastoma growth 62
D-amino acids in aging erythrocytes. 61
Biologie moléculaire et mèdecine 60
Hyperhomocysteinemia in ESRD. 59
MCP-1 in psoriatic patients: effect of biological therapy 58
Therapy of Hyperhomocysteinemia in Hemodialysis Patients: Effects of Folates and N-Acetylcysteine 58
D-aspartate content of erythrocyte membrane proteins is decreased in uremia: Implications for the repair of damaged proteins 58
Protein isoaspartate methyltransferase prevents apoptosis induced by oxidative stress in endothelial cells: role of Bcl-Xl deamidation and methylation. 57
Divergent behavior of hydrogen sulfide pools and of the sulfur metabolite lanthionine, a novel uremic toxin, in dialysis patients 57
Definition of microRNAs predictive of nodal involvement in laringeal cancer patients 57
Moderate hyperhomocysteinaemia and retinopathy in insulin-dependent diabetes 56
Hydroxytyrosol, a natural antioxidant from olive oil, prevents protein damage induced by long-wave ultraviolet radiation in melanoma cells. 56
Epigenetics in hyperhomocysteinemic states. A special focus on uremia 56
Increased Membrane‐Protein Methylation in Hereditary Spherocytosis: A Marker of Cytoskeletal Disarray 55
Hydrogen Sulfide, the Third Gaseous Signaling Molecule With Cardiovascular Properties, Is Decreased in Hemodialysis Patients 54
Plasma protein homocysteinylation in uremia 54
Enzymatic basis for the calcium-induced decrease of membrane protein methyl esterification in intact erythrocytes. Evidence for an impairment of S-adenosylmethionine synthesis 54
INSUFFICIENZA RENALE CRONICA 54
COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis 54
Repair of isopeptide bonds by protein carboxyl O-methyltransferase: seminal ribonuclease as a model system. 52
Increased methyl esterification of membrane proteins in aged red-blood cells. Preferential esterification of ankyrin and band-4.1 cytoskeletal proteins. 52
Metabolic consequences of hyperhomocysteinemia in uremia 52
Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients. 52
L-propionyl carnitine, homocysteine and S-adenosylhomocysteine in hemodialysis 52
Plasma proteins containing damaged L-isoaspartyl residues are increased in uremia: Implications for mechanism 52
Homocysteinylated albumin promotes increased monocyte-endothelial cell adhesion and up-regulation of MCP1, Hsp60 and ADAM17 52
Hyperhomocysteinemia and cardiovascular disease in uremia: The newest evidence in epidemiology and mechanisms of action 51
Hyperhomocysteinemia and protein damage in chronic renal failure and kidney transplant pediatric patients - Italian initiative on uremic hyperhomocysteinemia (IIUH) 51
Vasodilatation caused by endogenous hydrogen sulfide in chronic renal failure 51
Plasma homocysteine and its determinants in diabetic retinopathy [8] 51
Accumulation of altered aspartyl residues in erythrocyte proteins from patients with Down's syndrome. 51
Emerging ole of oxidative stress and its relation to homocysteine 51
Hypotheses on the physiological role of enzymatic protein methyl esterification using human erythrocytes as a model system. 50
Distinct C-terminal sequences of isozymes I and II of the human erythrocyte L-isoaspartyl/D-aspartyl protein methyltransferase. 50
Mechanism of protein carboxyl methyl transfer reactions: structural requirements of methyl accepting substrates. 50
Lanthionine and Other Relevant Sulfur Amino Acid Metabolites: Detection of Prospective Uremic Toxins in Serum by Multiple Reaction Monitoring Tandem Mass Spectrometry 50
Uremic Toxin Lanthionine Interferes with the Transsulfuration Pathway, Angiogenetic Signaling and Increases Intracellular Calcium 49
Dna methylation dysfunction in chronic kidney disease 49
Microsomal triglyceride transfer protein (MTP) -493G/T gene polymorphism contributes to fat liver accumulation in HCV genotype 3 infected patients 47
ENZYMATIC METHYL ESTERIFICATION OF ERYTHROCYTE-MEMBRANE PROTEINS IS IMPAIRED IN CHRONIC-RENAL-FAILURE - EVIDENCE FOR HIGH-LEVELS OF THE NATURAL INHIBITOR S-ADENOSYLHOMOCYSTEINE 47
Is Homocysteine Toxic in Uremia? 47
UVA-irradiation induces L-isoaspartyl formation in melanoma cell proteins 47
Plasma homocysteine and microvascular complications in type 1 diabetes 46
Decrease in membrane protein methyl esterification induced by calcium loading in intact human erythrocytes 46
No effect of MTP polymorphisms on PNPLA3 in HCV-correlated steatosis 46
Hyperhomocysteinemia in uremia - A red flag in a disrupted circuit 45
Homocysteine metabolism in renal failure 45
Homocysteine, a new cardiovascular risk factor, is also a powerful uremic toxin 45
Influence of osmotic stress on protein methylation in resealed erythrocytes 44
Membrane protein damage and methylation reactions in chronic renal failure 44
Enzymatic detection of L-isoaspartyl residues in food proteins and the protective properties of trehalose 44
Low hydrogen sulphide and chronic kidney disease: A dangerous liaison 43
Homocysteine and transmethylations in uremia 43
Specificity of endoproteinase Asp-N (Pseudomonas fragi): cleavage at glutamyl residues in two proteins. 43
MiR-17 and -20a target the neuron-derived orphan receptor-1 (NOR-1) in vascular endothelial cells 43
Occurrence of D-aspartic acid and N-methyl-D-aspartic acid in rat neuroendocrine tissues and their role in the modulation of luteinizing hormone and growth hormone release 42
Role of folic acid depletion on homocysteine serum level in children and adolescents with epilepsy and different MTHFR C677T genotypes. 42
Impaired transmethylation potential in Parkinson's disease patients treated with L-Dopa 42
miRNA-23a modulates sodium-hydrogen exchanger 1 expression: studies in medullary thick ascending limb of salt induced hypertensive rats 40
Possible mechanisms of homocysteine toxicity 40
The MicroRNA 15a/16-1 cluster down-regulates protein repair isoaspartyl methyltransferase in hepatoma cells: Implications for apoptosis regulation 39
MECHANISM OF ERYTHROCYTE ACCUMULATION OF METHYLATION INHIBITOR S-ADENOSYLHOMOCYSTEINE IN UREMIA 39
Hydrogen sulphide-generating pathways in haemodialysis patients: a study on relevant metabolites and transcriptional regulation of genes encoding for key enzymes 38
Methionine-enriched diet decreases hippocampal antioxidant defences and impairs spontaneous behaviour and long-term potentiation in rats 38
Increased plasma protein homocysteinylation in hemodialysis patients 38
Enzymatic methyl esterification in the processing of age-damaged proteins. 38
Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia 37
Review: Plasma protein homocysteinylation in uremia 37
Homocysteine in uremia 37
Iperomocisteinemia e rischio cardiovascolare negli uremici 37
Toxic effects of hyperhomocysteinemia in chronic renal failure and in uremia: Cardiovascular and metabolic consequences 36
Omocisteina: tossicità ed implicazioni cliniche e metaboliche 36
Homocysteine solution‐induced response in aerosol jet printed oects by means of gold and platinum gate electrodes 36
Human erythrocyte D-aspartyl/L-isoaspartyl methyltransferases: enzymes that recognize age-damaged proteins. 35
MTHFR C677T polymorphism and skin color: The white man's blackness [2] 35
Homocysteine and Hydrogen Sulfide, Two Opposing Aspects in the Pathobiology of Sulfur Compounds in Chronic Renal Failure 35
Plasma protein aspartyl damage is increased in hemodialysis patients: Studies on causes and consequences 34
Impact of parathyroidectomy on cardiovascular outcomes and survival in chronic hemodialysis patients with secondary hyperparathyroidism. A retrospective study of 50 cases prior to the calcimimetics era 34
Homocysteine and chronic kidney disease: an ongoing narrative 34
Protein damage and methylation-mediated repair in the erythrocyte 33
Totale 5.155
Categoria #
all - tutte 19.339
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.339


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201928 0 0 0 0 0 0 0 0 0 5 14 9
2019/2020784 135 124 25 19 115 14 154 40 66 34 43 15
2020/2021929 104 8 107 44 132 8 120 101 10 128 85 82
2021/2022806 83 7 12 31 277 9 5 20 32 63 54 213
2022/20231.759 146 34 30 152 232 138 4 89 838 25 31 40
2023/2024459 58 26 26 62 205 40 25 10 6 1 0 0
Totale 5.792